PharmaShots | Incisive News in 3 Shots

Subscribe Now

Wellmarker Bio

Wellmarker Bio Entered into a Clinical Trial Collaboration with MSD to evaluate WM-A1-3389 + Keytruda (pembrolizumab) for Non-Small Cell Lung Cancer

Wellmarker Bio Entered into a Clinical Trial Collaboration with MSD to evaluate WM-A1-3389 + Keytruda (pembrolizumab) for Non-Smal...

February 8, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us